ÖÐÎÄÃû³Æ£º Íÿ¹MAGEB5¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-MAGEB5 rabbit polyclonal antibody
±ð Ãû£º CT3.3; MAGE-B5
Ïà¹ØÀà±ð£ºÒ»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£©
ËÞ Ö÷£º Rabbit
¿¹ Ô£º MAGEB5
·´Ó¦ÖÖÊô£º Human
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
Background:
The melanoma-associated antigen (MAGE) family consists of a number of antigens recognized by cytotoxic T lymphocytes. The MAGE genes were initially isolated from different kinds of tumors and, based on their virtually exclusive tumor-specific expression in adult tissues, they have been used as targets for cancer immunotherapy. MAGE genes encode for tumor-rejection antigens that are expressed in tumors of different histologic types and in normal testis and placenta. MAGE-B5 (melanoma-associated antigen B5), also known as CT3.3 (cancer/testis antigen 3.3), is a 275 amino acid protein that contains one MAGE domain and is expressed in testis. The gene encoding MAGE-B5 maps to human chromosome X, which consists of about 153 million base pairs and nearly 1,000 genes. Color blindness, hemophilia and Duchenne muscular dystrophy are well known X chromosome-linked conditions which affect males more frequently, as males carry a single X chromosome.
Applications:
ELISA, IHC
Name of antibody:
MAGEB5
Immunogen:
Synthetic peptide of human MAGEB5
Full name:
MAGE family member B5
Synonyms:
CT3.3; MAGE-B5
SwissProt:
Q9BZ81
ELISA Recommended dilution:
5000-10000
IHC positive control:
Human thyroid cancer and human liver cancer
IHC Recommend dilution:
20-100


¹ºÎï³µ
°ïÖú
021-54845833/15800441009
